<DOC>
	<DOCNO>NCT01207622</DOCNO>
	<brief_summary>The primary objective study investigate efficacy Atomoxetine ( ATMX ) treatment adolescent young adult Attention Deficit Hyperactivity Disorder ( ADHD ) comorbid Substance Use Disorder ( SUD ) . The secondary objective study determine efficacy ATMX prevent SUD relapse . As previous pre-clinical work demonstrate ATMX lead significant improvement ADHD child lack abuse liability , investigator hypothesize ATMX efficacious treat ADHD adolescent young adult SUD , ATMX also efficacious prevent SUD relapse .</brief_summary>
	<brief_title>Efficacy Atomoxetine ADHD Adolescents Young Adults With SUD</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Male female outpatient 1530 year . Subjects DSMIV diagnosis ADHD ( combine inattentive subtype ) determine clinical evaluation and/or ADHD module structure diagnostic interview , complete study clinician . Subjects current recent ( within three month ) substance use disorder ( drug alcohol ) determine clinical evaluation and/or ascertain structure diagnostic interview . Subjects ADHD CGIS &gt; = 4 ( moderate impairment ) . Pregnant nursing female . Subjects clinically unstable medical condition either jeopardize patient safety affect scientific merit study , undergo change treatment study . Recent history intravenous drug use , subject current DSMIV criterion abuse dependence cocaine , MDA , MDMA , gammahydroxybutyrate , methamphetamine , amphetamine , opioids , PCP , benzodiazepines opinion investigator interfere ability participate safely study . Subjects Mental Retardation Organic Brain Syndromes . Subjects psychotic history bipolar disorder . Participants take psychotropic antiSUD medication exclude study . Current DSMIV diagnosis major depression , depressive disorder , anorexia manifest clinical interview .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>